NOVAVAX - RECENT DATA FROM PHASE 2 TRIAL LEAD US TO BELIEVE THAT OUR VACCINE IS LIKELY TO PROVIDE PROTECTION AGAINST NEW, EMERGING COVID-19 VARIANTS
Stock Market News in real time
- Stock Market
- Stock Market News in real time
- Economy
- Novavax - Recent Data From Phase 2 Trial Lead Us To Believe That Our Vaccine Is Likely To Provide Protection Against New, Emerging Covid-19 Variants